Keywords: ipsen, files, eu, approval, six-month, decapeptyl, france-based

Ipsen files for EU approval of six-month Decapeptyl

Article | 29 September 2008

Print This

France-based drugmaker Ipsen has submitted an application to the European Medicines Agency (EMEA) for the approval of its new six-month ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in